期刊文献+

中国耐多药结核分枝杆菌二线抗结核药物敏感性分析 被引量:31

Analysis of drug susceptibility profiles of multidrug-resistant M.tuberculosis isolated from China
暂未订购
导出
摘要 目的分析中国耐多药结核分枝杆菌(MDR-TB)菌株对二线抗结核药物的敏感性,为耐多药结核病防治政策的制定提供科学依据。方法从全国2007—2008年耐药基线调查收集的菌株中选取2008年4—7月期间耐药基线调查点收集的126株MDR菌株,对其进行2种一线抗结核药物(链霉素和乙胺丁醇)和7种二线抗结核药物(氧氟沙星、卡那霉素、卷曲霉素、乙硫异烟胺、丙硫异烟胺、环丝氨酸和对氨基水杨酸)的敏感性进行检测,分析对不同药物耐药率以及交叉耐药的情况。结果一线药物链霉素和乙胺丁醇,总体耐药率分别为73.0%(92/126)和58.7%(74/126);对于二线药物,氧氟沙星和乙硫异烟胺耐药率最高,分别为25.4%(32/126)和23.0%(29/126);其次为卡那霉素和环丝氨酸,其耐药率分别为17.5%(22/126)和13.5%(17/126);最后为卷曲霉素、丙硫异烟胺和对氨基水杨酸,其耐药率均为3.2%(4/126)。初治患者对卡那霉素(χ2=20.025,P<0.01)和环丝氨酸(χ2=6.558,P=0.017)的耐药率(卡那霉素:20/60,33.3%;环丝氨酸:13/60,21.7%)显著高于复治患者(卡那霉素:2/66,3.0%;环丝氨酸:4/66,6.1%)。此外,卡那霉素和卷曲霉素,乙硫异烟胺和丙硫异烟胺间均存在单向交叉耐药,在对卷曲霉素耐药的4株中,有3株同时对卡那霉素耐药;4株对丙硫异烟胺耐药菌株均同时对乙硫异烟胺耐药。结论我国耐多药结核分枝杆菌菌株对二线抗结核药物具有较高的耐药率,特别是氧氟沙星和乙硫异烟胺,这对我国结核病控制工作,特别是耐多药结核病控制工作的实施带来严峻的挑战。 Objective To analyze drug susceptibility profiles of multi-drug resistant (MDR) M. tuberculosis isolated from China, and provide the scientific evidence for MDR-tuberculosis (MDR-TB) control and prevention. Methods One hundred and twenty-six MDR isolates were selected from the first drug resistant survey in China be- tween April 2008 and July 2008. The conventional drug susceptibility testing was used to detect the drug-resistant profiles against 2 first-line (streptomycin and ethambuol) and 7 second-line anti-tuberculosis drugs (ofloxacin, kana- mycin, capreomyein, ethionamide, protionamide,cycloserine and 4-Amino-2-hydroxybenzoicacid). The drug-resist- ant proportion and cross resistance were analyzed. Results For first-line drugs, the drug-resistant proportions against streptomycin and ethambuol were 73.0% (92/126) and 58.7% (74/126), respectively. For second-line drugs, the percentages of the resistance to ofloxacin and ethionamide were the highest, accounting for 25.4% (32/126) and 23.0% (29/126), respectively. Then, 17.5% (22/126) and 13.5% (17/126) of MDR strains were resistant to kanamycin and cycloserine, respectively. In addition, the drug-resistant rates of capreomycin, pro- tionamide and 4-Amino-2-hydroxybenzoicaeid were all 3. 2% (4/126). The drug-resistant proportions of kanamycin (χ22= 20. 025,P〈0.01) and cysloserine (χ2= 6. 558, P = 0. 017) in new case group were significantly higher than that in re-treated case group. In addition, there were the cross-resistances between kanamycin and capreomycin, or ethionamide and protionamide. Three of four capreomycin-resistant isolates were resistant to kanamycin, and all four protionamide-resistant strains were resistant to ethionamide meanwhile. Conclusion The high prevalence of M. tuberculosis strains with the resistance to second-line anti-tuberculosis drugs, especially to ofloxacin and ethio- namide in MDR-TB patients was the major challenge on the prevention and control of TB and MDR-TB in China.
出处 《中国防痨杂志》 CAS 2013年第10期831-834,共4页 Chinese Journal of Antituberculosis
基金 中国卫生部与比尔及梅琳达.盖茨基金会结核病防治项目(2009-04-01)
关键词 枝杆菌 结核 抗药性 多种 细菌 抗生素类 抗结核 微生物敏感性试验 Mycobacterium tuberculosis Drug resistance, multiple, bacterial Antibiotics, antitubercular Microbial sensitivity tests
  • 相关文献

参考文献12

  • 1World Health Organization. Anti-tuberculosis drug resistance in the world: fourth global report[R/OL]. Geneva: WHO, 2008. [ 2013 08 04]. http://whqlibdoc, who. int/hq/2008/ WHO_HTM TB 2008. 394_eng. pdf.
  • 2World Health Organization. Multidrug and extensively drug- resistant TB (M/XDR-TB) : 2010 global report on surveillance and response[R/OL]. Geneva: WHO, 2010. [2013-08-04], http://whqlibdoc; who. int / publications/ 2010 / 9 7 892415 99191 _ eng. pdf.
  • 3leon CY, Hwang SH, Min JH, et al. Extensively drug resis- tant tuberculosis in South Korea: risk factors and treatment outcomes among patients at a tertiary referral hospital. Clin Infect Dis, 2008, 46(1): 42-49.
  • 4Toungoussova OS, Mariandyshev AO, Bjune G, et al. Resis- tance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuber- culosis drugs. Eur J Clin Microbiol Infect Dis, 2005, 24(3) 202-206.
  • 5中华人民共和国卫生部.全国结核病耐药性基线调查报告(2007-2008年).北京:人民卫生出版社,2010:4.
  • 6中国防痨协会基础专业委员会.结核病诊断实验室检验规程.北京:中国教育出版社,2006,46-51.
  • 7王海英,王燕,于春宝,左云,王俊玲,刘志敏.2004~2007年山东省部分结核分枝杆菌耐药情况检测分析[J].预防医学论坛,2008,14(12):1075-1076. 被引量:13
  • 8张国龙,杜长梅,苍泽卓也,池田雄史,王伟,石瑞如.中日合作对河南省结核菌二线药物耐药监测研究[J].医药论坛杂志,2005,26(19):14-16. 被引量:15
  • 9沈鑫,李静,高谦,徐飚,梅建.2009年上海市耐药肺结核患者二线抗结核药物耐药状况调查[J].中华结核和呼吸杂志,2011,34(6):451-453. 被引量:28
  • 10周美兰,陈梓,王坚杰,陈聪,潘宏,焦新光.武汉市涂阳肺结核患者耐药率及耐药谱分析[J].中国防痨杂志,2013,35(2):97-102. 被引量:30

二级参考文献60

共引文献223

同被引文献406

引证文献31

二级引证文献609

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部